Skip to content

A registration study of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

A registration study of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041792
Enrollment
Unknown
Registered
2021-01-05
Start date
2021-01-20
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CADASIL

Interventions

case series:Nil

Sponsors

Shanghai Ninth Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: To meet both the following clinical criteria (1) - (5) and Notch3 gene test criteria. 1. Clinical criteria: (1) Age of onset (clinical symptom (2) or white matter lesion) <= 55 years old; (2) At least 2 of the following clinical symptoms: a. Subcortical dementia, or pyramidal tract sign, or bulbar palsy; b. Stroke events with focal symptoms; c. Emotional disorder; d. Migraine. (3) Autosomal dominant inheritance; (4) White matter hyperintensity with temporal pole involvement on MRI or CT; (5) Exclusion of leukodystrophy (such as adrenoleukodystrophy, metachromatic leukodystrophy, etc.). 2. Notch3 gene test criteria: Pathogenic or possibly pathogenic mutations in exons 2-24 of Notch3 gene sequencing, according to the genetic variation interpretation guidelines issued by ACMG in 2015.

Exclusion criteria

Exclusion criteria: No finding of pathogenic or possibly pathogenic mutations in exons 2-24 of Notch3 gene sequencing, according to the genetic variation interpretation guidelines issued by ACMG in 2015.

Design outcomes

Primary

MeasureTime frame
gene test;

Secondary

MeasureTime frame
cranial MRI;stroke events;cognitive function;blood test;

Countries

China

Contacts

Public ContactJing-Jing Su

Shanghai Ninth Hospital, Shanghai Jiao Tong University School of Medicine

jingjingsu2000@163.com+86 13761034024

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026